News / Events

Press Releases

  • November 17, 2008

    JUBILANT AUGMENTS CLINSYS CLINICAL RESEARCH® THROUGH ACQUISITION OF TRIALSTAT CLINICALANALYTICS®, AN EDC PLATFORM
    Download PDF | View Short Summary

    NOIDA, INDIA (November 17, 2008) - Jubilant Organosys Ltd. announced today that its subsidiary Clinsys Clinical Research, Inc.®, New Jersey, a global contract research organization (CRO), has acquired TrialStat ClinicalAnalytics® from TrialStat® for a purchase consideration of CAD 750,000.

    TrialStat ClinicalAnalytics (TrialStat CA) is a Web-based electronic data capture (EDC) solution currently used by a wide range of pharmaceutical and CRO customers worldwide. TrialStat CA is the industry's first EDC platform to allow all aspects of a study to be configured, deployed and managed through a browser interface, enabling customers to start their studies quickly and cost-effectively.

    Clinsys extensive global resources will enable TrialStat to continue its proven record of growth, customer service and product innovation. This agreement will give TrialStat's existing CRO and biopharmaceutical customer base a broader scope of services.

    "The Company had identified TrialStat ClinicalAnalytics as one of the most innovative EDC solutions on the market and was determined to include it in its offerings to its customers globally" said David E. Williams, Chief Executive Officer of Clinsys.

  • October 1, 2008

    CLINSYS® SUPPORTS BREAST CANCER RESEARCH THROUGH PASSIONATELY PINK FOR THE CURE® INITIATIVE
    Download PDF | View Short Summary

    BEDMINSTER, NEW JERSEY (October 1, 2008) - Clinsys Clinical Research, a therapeutically focused global contract research organization, today announced the launch of its Passionately Pink for the Cure® campaign, a company-wide breast cancer awareness and fundraising program supporting Susan G. Komen for the Cure® . All donations received through the year-long Clinsys Passionately Pink campaign will be matched by the company.

    Passionately Pink for the Cure is a national grassroots program in which companies, organizations, social groups and individuals select a day to wear pink, and each group member donates $5 or more to Komen for the Cure. Of the donations received through Passionately Pink for the Cure, 75 percent will go toward breast cancer research, and the remaining 25 percent will be shared with Komen affiliates to support local education, screening and treatment efforts.

  • July 31, 2008

    CLINSYS® DIRECTOR RECOGNIZED AS INDUSTRY INSPIRATION
    Download PDF | View Short Summary

    BEDMINSTER, NEW JERSEY (July 31, 2008) - Clinsys Clinical Research, a therapeutically focused global contract research organization, today announced that Nila Williams, Director, Customer Relations and Global Training, has been selected as one of the "100 Most Inspiring People in the Life-Sciences Industry in 2008" by the readers of PharmaVOICE magazine. Recognition is based on how individuals have inspired and motivated those around them, their influence as a corporate leader, and how their actions have positively impacted the industry.

  • May 30, 2008

    CLINSYS® PARTNERS WITH MEDIDATA SOLUTIONS THROUGH ASPIRE TO WIN PARTNER PROGRAM
    Download PDF | View Short Summary

    NEW YORK, N.Y. and BEDMINSTER, N.J.- May 30, 2008 - Medidata Solutions, a leading provider of clinical trial solutions, and Clinsys Clinical Research, Inc.® , a therapeutically focused global contract research organization (CRO), today announced that the two companies have partnered through Medidata's ASPire to Win® program. The partnership will enable Clinsys to implement the Medidata Rave® technology for capturing, managing and reporting clinical data as a complement to its focus on superior service delivery for sponsors in the U.S., Europe and India.

    Clinsys provides pharmaceutical, biotechnology and medical device companies with a full range of clinical research services in support of Phase I-IV drug and device development. With extensive experience and expertise in specialized therapeutic areas including oncology, central nervous system, dermatology, respiratory and cardiovascular, Clinsys looked for an electronic data capture (EDC) partner that offered innovative Web-based technology with secure, reliable and scalable hosting, in order to reduce both implementation time and total cost of ownership. Clinsys selected Medidata as its EDC provider due to sponsor demand for Rave's Web-based, site-friendly features that help to increase EDC usage.

  • May 28, 2008

    JUBILANT SUCCESSFULLY COMPLETES ACQUISITION OF DRAXIS
    Download PDF | View Short Summary

    INDIA (May 28, 2008) - Jubilant Organosys Ltd., an integrated pharmaceutical industry player and India's largest Custom Research and Manufacturing Services (CRAMS) company, today announced the completion of the transaction to acquire Canada-based DRAXIS Health Inc. (DRAXIS) for US $253 million. DRAXIS operates an FDA-approved manufacturing facility in Montreal, Canada, and employs approximately 500.

    DRAXIS offers products in three categories: sterile products, non-sterile products and radiopharmaceuticals. Sterile products include liquid and freeze-dried (lyophilized) injectables plus sterile ointments and creams. Non-sterile products are produced as solid oral and semi-solid dosage forms. Radiopharmaceuticals are used for both therapeutic and diagnostic molecular imaging applications.

  • April 10, 2008

    CLINSYS® REDEFINES RESOURCE SERVICES WITH THE LAUNCH OF CLINSYS ALTERNA™
    Download PDF | View Short Summary

    BEDMINSTER, NEW JERSEY (April 10, 2008) - Clinsys Clinical Research, a therapeutically focused global contract research organization, today announced the launch of Clinsys ALTERNA, which utilizes its Global Project Solution® (Clinsys GPS®) to augment clinical resource services. The new division demonstrates Clinsys' commitment to aligning its service offerings with its sponsors' and the life sciences industry's continuously evolving staffing needs.

    Clinsys ALTERNA provides customized Phase I-IV clinical trial alternative solutions to the conventional outsourcing model. The division is a core element of Clinsys GPS, a unique, highly effective and proven integrated project management solution that brings the sponsor and the Clinsys project teams together to collaborate and agree on all aspects of the clinical study—before, during and after—to ensure the project's success.

  • April 9, 2008

    CLINSYS® TPS TEAMS PROVIDE COMPREHENSIVE CLINICAL DEVELOPMENT PLANS

    Download PDF | View Short Summary

    CLINSYS® TPS TEAMS PROVIDE COMPREHENSIVE CLINICAL DEVELOPMENT PLANS

    BEDMINSTER, NEW JERSEY - April 9, 2008 - Clinsys Clinical Research, Inc.®, a therapeutically focused global contract research organization (CRO), today introduced its Therapeutically-aligned Program Strategists (TPS), an innovative concept for the evaluation and execution of clinical trials. The TPS teams are comprised of highly skilled and experienced professionals with defined therapeutic expertise who evaluate, create and execute all sponsor projects, from clinical development plans and clinical trial design through protocol finalization, leading to successful trial conduct.

    Each TPS team consists of MDs, PhDs and a clinical operations program director with expertise in a specific therapeutic area. These strategists apply a research-oriented approach to clinical trial strategy, design and execution to either deliver a comprehensive clinical development plan or protocol, or review and critique client synopses and protocols. The TPS team also provides analysis of the competitive environment, the current standards of care and market potential. TPS services extend to design and implementation of generic and bioavailability/bioequivalence (BA/BE) trials.

  • December 17, 2007

    CLINSYS CLINICAL RESEARCH, INC. AND ITEC SERVICES ESTABLISH STRATEGIC ALLIANCE TO EXPAND CRO OFFERINGS GLOBALLY

    Download PDF | View Short Summary

    CLINSYS CLINICAL RESEARCH, INC. AND ITEC SERVICES ESTABLISH STRATEGIC ALLIANCE TO EXPAND CRO OFFERINGS GLOBALLY

    BEDMINSTER, NEW JERSEY and BORDEAUX, FRANCE - December 17, 2007 - Clinsys Clinical Research, Inc. and ITEC Services, both therapeutically focused clinical research organizations, today announced they have entered into a strategic alliance agreement that will broaden each company's global clinical research service offering. The alliance will enable Clinsys to extend its global clinical operations and consulting services in Europe and North Africa, while providing ITEC increased opportunities resulting from alignment with Clinsys' infrastructure and network of global resources in the United States, India and Western Europe.

    Established in 1984, ITEC, headquartered in Bordeaux, France, with operations in Casablanca, Morocco, has rapidly expanded its comprehensive range of clinical research services in response to the accelerating changes in the pharmaceutical industry in France and Western Europe.

  • October 8, 2007

    CLINSYS CLINICAL RESEARCH, INC. ANNOUNCES RELOCATION OF CORPORATE HEADQUARTERS

    Download PDF | View Short Summary

    CLINSYS CLINICAL RESEARCH, INC. ANNOUNCES RELOCATION OF CORPORATE HEADQUARTERS

    BERKELEY HEIGHTS, NEW JERSEY - October 8, 2007 - Clinsys Clinical Research, Inc., a therapeutically focused clinical research organization, today announced the relocation of its corporate headquarters to accommodate the company's significant growth and plans for future expansion. The new, larger facility is located in Bedminster, New Jersey.

    "Our new headquarters, combined with our recent expansion of operations in Raleigh, North Carolina and Düsseldorf, Germany, offers many advantages to Clinsys and our sponsors," said David E. Williams, Chief Executive Officer of Clinsys Clinical Research. Mr. Williams continues, "The relocation strategically keeps Clinsys in the center of one of the largest biopharmaceutical clusters and experienced employee pools in the country. Our new headquarters will afford us enhanced operational performance from which to continue to provide exceptional service to our existing and new sponsors."

  • September 10, 2007

    CLINSYS CLINICAL RESEARCH, INC. ANNOUNCES KEY HIRES, RAJAGOPALAN SRINIVASAN, Ph.D. AND CHRISTOPHER GREGORY, Ph.D.

    Download PDF | View Short Summary

    CLINSYS CLINICAL RESEARCH, INC. ANNOUNCES KEY HIRES, RAJAGOPALAN SRINIVASAN, Ph.D., TO STRENGTHEN GLOBAL BIOSTATISTICS SERVICE OFFERING AND CHRISTOPHER GREGORY, Ph.D., TO SCIENTIFIC AFFAIRS

    BERKELEY HEIGHTS, NEW JERSEY / RALEIGH, NORTH CAROLINA, September 10, 2007 - Clinsys Clinical Research, Inc., a therapeutically focused clinical research organization, today announced the appointments of Rajagopalan Srinivasan, Ph.D. as Vice President, Global Biostatistics and Christopher Gregory, Ph.D. as Scientific Affairs - Director.

    "I am excited to have Drs. Srinivasan and Gregory, both highly experienced professionals in their respective fields in clinical research, join the Clinsys team," said David E. Williams, Chief Executive Officer of Clinsys Clinical Research. Mr. Williams continues, "Dr. Srinivasan, who will head up our global biostatistics service offering, brings substantial expertise in biostatistics directly relating to our key therapeutic areas of Oncology, Cardiovascular and CNS. Dr. Gregory, who will serve as a senior scientific advisor for our clinical project teams, brings a wealth of direct pharmaceutical research development and academic experience to support our global regulatory and scientific affairs services."

  • August 13, 2007

    CLINSYS CLINICAL RESEARCH, INC. ANNOUNCES KEY HIRE, HARTMUT SCHMIED, MD.

    Download PDF | View Short Summary

    CLINSYS CLINICAL RESEARCH, INC. ANNOUNCES KEY HIRE, HARTMUT SCHMIED, MD, TO STRENGTHEN EUROPEAN SERVICE OFFERING AND GLOBAL CARDIOVASCULAR THERAPEUTIC STRATEGY

    BERKELEY HEIGHTS, NEW JERSEY August 13, 2007 - Clinsys Clinical Research, Inc., a therapeutically focused clinical research organization, today announced the appointment of Hartmut Schmied, MD as Vice President, European Operations, based in the company's Düsseldorf, Germany facility.

    "I am excited to have Dr. Schmied, a highly experienced professional in the field of cardiovascular clinical research join the Clinsys team. Dr. Schmied will have direct responsibility for Clinsys' European clinical research operations and will also head up our Cardiovascular Therapeutic Area," said David E. Williams, Chief Executive Officer of Clinsys Clinical Research. Mr. Williams continues, "The addition of Dr. Schmied, who brings both substantial clinical and management expertise, will be extremely beneficial in continuing to establish Clinsys as a global industry leader."

  • June 18, 2007

    CLINSYS CLINICAL RESEARCH, INC. EXPANDS GLOBAL OPERATIONS

    Download PDF | View Short Summary

    CLINSYS CLINICAL RESEARCH, INC. EXPANDS GLOBAL OPERATIONS: ANNOUNCES OFFICES OPENING IN RALEIGH, NORTH CAROLINA; DUSSELDORF, GERMANY AND GENT, BELGIUM

    BERKELEY HEIGHTS, NEW JERSEY | 18 June 2007 - Clinsys Clinical Research, Inc., a therapeutically focused Clinical Research Organization, today announced the expansion of its United States and European operations by opening offices in Raleigh, North Carolina; Dusseldorf, Germany and Gent, Belgium.

    "I am excited that our growth and need to service more of our sponsors' global requests has required that we expand our United States and European operations," said David E. Williams, Chief Executive Officer of Clinsys Clinical Research. Mr. Williams continues, "We have selected these locations as they are central to our sponsors, have a strong employee talent pool to choose from and provide easy access to both Western and Eastern Europe. These expansions will allow Clinsys to offer a full range of clinical trial services in support of global as well as local clinical trials."

  • April 30, 2007

    CLINSYS CLINICAL RESEARCH, INC. ANNOUNCES KEY HIRES TO STRENGTHEN SERVICE OFFERING AND GLOBAL THERAPEUTIC STRATEGY

    Download PDF | View Short Summary

    CLINSYS CLINICAL RESEARCH, INC. ANNOUNCES KEY HIRES TO STRENGTHEN SERVICE OFFERING AND GLOBAL THERAPEUTIC STRATEGY: ANTHONY F. ABRUZZINI, Ph.D AS VICE PRESIDENT, GLOBAL REGULATORY SERVICES; LINDA PATRICIA MILLER, MD AS CHIEF MEDICAL OFFICER AND JOHN K. HOGAN, MPM AS PROJECT DIRECTOR FOR CNS

    BERKELEY HEIGHTS, NEW JERSEY | 30 April 2007 - Clinsys Clinical Research, Inc., a therapeutically focused Clinical Research Organization, today announced the appointment of Anthony Abruzzini, Ph.D as Vice President, Global Regulatory Services; Linda Patricia Miller, MD as Chief Medical Officer; and John Hogan, MPM as Project Director for the Central Nervous System (CNS) therapeutic area franchise.

    "I am excited to have three highly experienced professionals join the Clinsys team." said David E. Williams, Chief Executive Officer of Clinsys Clinical Research. Mr. Williams continues, "The addition of Dr. Abruzzini and Dr. Miller, who both bring substantial clinical and management expertise, will be extremely beneficial in continuing to establish Clinsys as an industry leader. John Hogan brings years of experience managing full service CNS projects."

  • Feburary 15, 2007

    CLINSYS, INC. CHANGES NAME TO CLINSYS CLINICAL RESEARCH, INC.

    Download PDF | View Short Summary

    CLINSYS, INC. TODAY ANNOUNCED THAT IT IS CHANGING ITS NAME TO CLINSYS CLINICAL RESEARCH, INC.

    BERKELEY HEIGHTS, NEW JERSEY | February 15, 2007 - Clinsys, Inc., today announced that it is changing its name to Clinsys Clinical Research, Inc., to reflect its more focused corporate direction, clearly defined global strategy and clinical operations capabilities.

    "In order to effectively meet the expectations of our sponsors we have integrated our global operations under one platform giving us increased capabilities with greater efficiency and enhanced quality," said David E. Williams, appointed Chief Executive Officer of Clinsys last November. Mr. Williams continues, "We have expanded and grown beyond the company we were even a year ago and continue building a unique client-focused organization with an enhanced service offering and a therapeutically-focused direction. Our company branding must evolve to clearly communicate these changes along with our commitment to our sponsors' success. Today, we are changing our name to Clinsys Clinical Research, reflecting our heritage and our new capabilities."